LGVAX — ClearBridge Value Trust
Data updated: 2026-06-22
LGVAX — ClearBridge Value Trust data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Large Cap Value Equity · $4.17B AUM · 1.01% expense ratio · 28.6% 1-yr return. From SEC regulatory filings.
LGVAX Fund Overview
LGVAX — ClearBridge Value Trust is a US mutual fund managed by Legg Mason Global Asset Management Trust, categorised as United States Large Cap Value Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Legg Mason Global Asset Management Trust
- Category: United States Large Cap Value Equity
- Assets under management: $4.17B
- 1-year return: 28.6%
- Ticker: LGVAX
- SEC CIK: 0001474103
- SEC series ID: S000036164
- Share class ID: C000110727
LGVAX Holdings
Top 10 holdings of ClearBridge Value Trust by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Alphabet, Inc. | 5.72% |
| Bank Of America Corp. | 3.46% |
| Micron Technology, Inc. | 3.10% |
| Johnson & Johnson | 3.03% |
| Amazon.com, Inc. | 2.80% |
| Chevron Corp. | 2.78% |
| Conocophillips | 2.49% |
| Unitedhealth Group, Inc. | 2.22% |
| Cvs Health Corp. | 2.15% |
| Walt Disney Company (the) | 2.06% |
LGVAX Portfolio Allocation
Asset-class allocation of ClearBridge Value Trust by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.2% |
| Cash & Equivalents | 0.7% |
LGVAX Performance
Total returns for LGVAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 9.8% |
| 1 year | 28.6% |
| 3 years (annualised) | 16.9% |
| 5 years (annualised) | 10.5% |
LGVAX Risk Information
Risk metrics for LGVAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 12.6%
LGVAX Costs and Fees
LGVAX costs about $101 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.01%
- Gross expense ratio: 1.04%
- Portfolio turnover: 53%
- Brokerage commissions: 5.66 bps of average net assets (SEC N-CEN)
LGVAX Cashflows
Over the 12 months to 2026-04, ClearBridge Value Trust had net inflows of $4.13M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$21.77M |
| 2026-03 | −$24.80M |
| 2026-02 | −$21.94M |
| 2026-01 | −$33.64M |
| 2025-12 | $297.37M |
| 2025-11 | −$24.11M |
LGVAX Debt Constituents
No individual debt constituents are reported in ClearBridge Value Trust's latest SEC N-PORT filing.
LGVAX Prospectus and SEC Filings
Official ClearBridge Value Trust filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Large Cap Value Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.